{"id":"https://openalex.org/W2585095576","doi":"https://doi.org/10.1111/dom.12889","title":"Novel oral glucose\u2010lowering drugs are associated with lower risk of all\u2010cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetes","display_name":"Novel oral glucose\u2010lowering drugs are associated with lower risk of all\u2010cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetes","alternate_titles":[],"publication_year":2017,"publication_date":"2017-03-16","ids":{"openalex":"https://openalex.org/W2585095576","doi":"https://doi.org/10.1111/dom.12889","mag":"2585095576","pmid":"https://pubmed.ncbi.nlm.nih.gov/28116795","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5485030"},"language":"en","primary_location":{"id":"doi:10.1111/dom.12889","doi":"https://doi.org/10.1111/dom.12889","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.12889","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12889","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2585095576"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12889","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014420723","display_name":"Thomas Nystr\u00f6m","orcid":"https://orcid.org/0000-0002-3462-7990","observed_orcids":["https://orcid.org/0000-0002-3462-7990"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]},{"id":"https://openalex.org/I4210094988","display_name":"Stockholm South General Hospital","ror":"https://ror.org/00ncfk576","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210094988"]}],"countries":["SE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Thomas Nystr\u00f6m","raw_affiliation_strings":["Unit for Diabetes Research, Division of Internal Medicine, Department of Clinical Science and Education, Karolinska Institute S\u00f6dersjukhuset  Stockholm Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit for Diabetes Research, Division of Internal Medicine, Department of Clinical Science and Education, Karolinska Institute S\u00f6dersjukhuset  Stockholm Sweden","institution_ids":["https://openalex.org/I28166907","https://openalex.org/I4210094988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015552621","display_name":"Johan Bodeg\u00e5rd","orcid":"https://orcid.org/0000-0001-5423-3967","observed_orcids":["https://orcid.org/0000-0001-5423-3967"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Johan Bodegard","raw_affiliation_strings":["AstraZeneca Nordic\u2010Baltic  S\u00f6dert\u00e4lje Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca Nordic\u2010Baltic  S\u00f6dert\u00e4lje Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109321925","display_name":"David Nathanson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]},{"id":"https://openalex.org/I4210094988","display_name":"Stockholm South General Hospital","ror":"https://ror.org/00ncfk576","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210094988"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David Nathanson","raw_affiliation_strings":["Unit for Diabetes Research, Division of Internal Medicine, Department of Clinical Science and Education, Karolinska Institute S\u00f6dersjukhuset  Stockholm Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit for Diabetes Research, Division of Internal Medicine, Department of Clinical Science and Education, Karolinska Institute S\u00f6dersjukhuset  Stockholm Sweden","institution_ids":["https://openalex.org/I28166907","https://openalex.org/I4210094988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091007028","display_name":"Marcus Thuresson","orcid":"https://orcid.org/0000-0001-5431-9365","observed_orcids":["https://orcid.org/0000-0001-5431-9365"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]},{"id":"https://openalex.org/I4210099778","display_name":"Saint G\u00f6ran Hospital","ror":"https://ror.org/00x6s3a91","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210099778"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marcus Thuresson","raw_affiliation_strings":["Capio S:t G\u00f6rans Hospital  Stockholm Sweden","Cardiology Unit, Department of Medicine, Solna, Karolinska Institute, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Capio S:t G\u00f6rans Hospital  Stockholm Sweden","institution_ids":["https://openalex.org/I4210099778"]},{"raw_affiliation_string":"Cardiology Unit, Department of Medicine, Solna, Karolinska Institute, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020184441","display_name":"Anna Norhammar","orcid":"https://orcid.org/0000-0002-4467-0132","observed_orcids":["https://orcid.org/0000-0002-4467-0132"]},"institutions":[{"id":"https://openalex.org/I4210161621","display_name":"Statisticon (Sweden)","ror":"https://ror.org/05a781r26","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210161621"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anna Norhammar","raw_affiliation_strings":["Statisticon AB, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Statisticon AB, Uppsala, Sweden","institution_ids":["https://openalex.org/I4210161621"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044288681","display_name":"Jan W. Eriksson","orcid":"https://orcid.org/0000-0002-2639-9481","observed_orcids":["https://orcid.org/0000-0002-2639-9481"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jan W. Eriksson","raw_affiliation_strings":["Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden"],"raw_orcid":"https://orcid.org/0000-0002-2639-9481","affiliations":[{"raw_affiliation_string":"Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5014420723"],"corresponding_institution_ids":["https://openalex.org/I28166907","https://openalex.org/I4210094988"],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":{"value":5380,"currency":"USD","value_usd":5380},"fwci":9.0928,"has_fulltext":true,"cited_by_count":82,"citation_normalized_percentile":{"value":0.9876811,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"19","issue":"6","first_page":"831","last_page":"841"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9409999847412109},{"id":"https://openalex.org/keywords/insulin","display_name":"insulin","score":0.6970000267028809},{"id":"https://openalex.org/keywords/dapagliflozin","display_name":"dapagliflozin","score":0.9380000233650208},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9279999732971191},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":1.0},{"id":"https://openalex.org/keywords/all-cause-mortality","display_name":"all-cause mortality","score":0.9909999966621399},{"id":"https://openalex.org/keywords/cardiovascular-events","display_name":"cardiovascular events","score":0.9440000057220459},{"id":"https://openalex.org/keywords/severe-hypoglycemia","display_name":"severe hypoglycemia","score":0.9819999933242798},{"id":"https://openalex.org/keywords/comparative-effectiveness","display_name":"comparative effectiveness","score":0.5210000276565552},{"id":"https://openalex.org/keywords/propensity-score-matching","display_name":"propensity score matching","score":0.593999981880188},{"id":"https://openalex.org/keywords/empagliflozin","display_name":"empagliflozin","score":0.722000002861023}],"concepts":[{"id":"https://openalex.org/C2777422806","wikidata":"https://www.wikidata.org/wiki/Q409898","display_name":"Dapagliflozin","level":4,"score":0.9169725179672241},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8780962228775024},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.7963277101516724},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.7037185430526733},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7009289860725403},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6264120936393738},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.54915452003479},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.5391460061073303},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.5209602117538452},{"id":"https://openalex.org/C2779668873","wikidata":"https://www.wikidata.org/wiki/Q6693756","display_name":"Lower risk","level":3,"score":0.4326073229312897},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3917011022567749},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.34752845764160156}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001559","descriptor_name":"Benzhydryl Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D002423","descriptor_name":"Cause of Death","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005960","descriptor_name":"Glucosides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012042","descriptor_name":"Registries","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013548","descriptor_name":"Sweden","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D057216","descriptor_name":"Propensity Score","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1111/dom.12889","doi":"https://doi.org/10.1111/dom.12889","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.12889","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12889","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5485030","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5485030/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Obes Metab","raw_type":"Text"},{"id":"pmid:28116795","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28116795","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Journal Article"},{"id":"pmh:oai:DiVA.org:uu-324228","doi":null,"is_oa":true,"landing_page_url":"http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-324228","pdf_url":null,"source":{"id":"https://openalex.org/S4306402042","display_name":"Uppsala University Publications (Uppsala University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I123387679","host_organization_name":"Uppsala University","host_organization_lineage":["https://openalex.org/I123387679"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1111/dom.12889","doi":"https://doi.org/10.1111/dom.12889","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.12889","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12889","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2585095576.pdf","grobid_xml":"https://content.openalex.org/works/W2585095576.grobid-xml"},"referenced_works_count":49,"referenced_works":["https://openalex.org/W172609984","https://openalex.org/W1484265493","https://openalex.org/W1526927233","https://openalex.org/W1532170875","https://openalex.org/W1834962231","https://openalex.org/W1914121615","https://openalex.org/W1914420255","https://openalex.org/W1975663485","https://openalex.org/W1976833777","https://openalex.org/W1982912756","https://openalex.org/W1983269691","https://openalex.org/W1997175144","https://openalex.org/W2020872000","https://openalex.org/W2033900534","https://openalex.org/W2045872180","https://openalex.org/W2064130493","https://openalex.org/W2068376155","https://openalex.org/W2073977794","https://openalex.org/W2084312430","https://openalex.org/W2087025850","https://openalex.org/W2089198100","https://openalex.org/W2095682936","https://openalex.org/W2097927972","https://openalex.org/W2097995302","https://openalex.org/W2111876001","https://openalex.org/W2112064962","https://openalex.org/W2127854619","https://openalex.org/W2128243640","https://openalex.org/W2131830909","https://openalex.org/W2142830692","https://openalex.org/W2145955362","https://openalex.org/W2146264128","https://openalex.org/W2157836715","https://openalex.org/W2160088494","https://openalex.org/W2166018731","https://openalex.org/W2172193326","https://openalex.org/W2193379135","https://openalex.org/W2222285657","https://openalex.org/W2243425339","https://openalex.org/W2301210108","https://openalex.org/W2346794292","https://openalex.org/W2411507632","https://openalex.org/W2425644022","https://openalex.org/W2503232483","https://openalex.org/W2516334143","https://openalex.org/W2523736413","https://openalex.org/W2565937008","https://openalex.org/W2582743722","https://openalex.org/W3122049309"],"related_works":["https://openalex.org/W2611895567","https://openalex.org/W2981661511","https://openalex.org/W2565937008","https://openalex.org/W2618210320","https://openalex.org/W2808816711","https://openalex.org/W2224892378","https://openalex.org/W2496417386","https://openalex.org/W2619082960","https://openalex.org/W6902477787","https://openalex.org/W3135826818"],"abstract_inverted_index":{"AIMS:":[0],"To":[1],"investigate":[2],"the":[3,64,76,85,193],"association":[4],"of":[5,14,18,44,89,133,178,203,231,259,277,293],"novel":[6,45,93,124,148,195],"oral":[7,46,251],"glucose-lowering":[8],"drugs":[9],"(GLDs),":[10],"compared":[11,185,266],"with":[12,16,34,67,129,147,152,186,200,228,242,256,267,273,290],"that":[13],"insulin,":[15],"risk":[17,177,230,258,276,292],"all-cause":[19,179,204,232,260,279,294],"mortality,":[20,180,261],"cardiovascular":[21],"disease":[22],"(CVD)":[23],"and":[24,82,87,96,139,170,182,206,214,263,281],"severe":[25,264],"hypoglycaemia.":[26],"METHODS:":[27],"During":[28],"2013":[29],"to":[30,110,123],"2014":[31],"all":[32],"patients":[33],"type":[35],"2":[36],"diabetes":[37],"in":[38,61,75,84],"Sweden":[39,62],"identified":[40],"as":[41,71],"new":[42],"users":[43],"GLDs,":[47,196],"either":[48],"dipeptidyl":[49],"peptidase-4":[50],"(DPP-4)":[51],"inhibitors":[52,57],"or":[53],"sodium-glucose":[54],"cotransporter-2":[55],"(SGLT2)":[56],"(only":[58],"dapagliflozin":[59,197],"available":[60],"during":[63],"study":[65],"period),":[66],"those":[68],"initiating":[69],"insulin":[70,97,127,187,268],"a":[72,153,274],"comparison":[73],"group,":[74],"Prescribed":[77],"Drug":[78],"Register":[79],"were":[80,99,108,120],"included":[81],"followed":[83],"Patient":[86],"Cause":[88],"Death":[90],"Registers.":[91],"The":[92],"GLD":[94,125,252],"group":[95,98],"matched":[100,121],"1:1":[101,122],"using":[102],"propensity":[103],"score.":[104],"Cox":[105],"regression":[106],"models":[107],"used":[109],"estimate":[111],"risks.":[112],"RESULTS:":[113],"Of":[114],"37":[115],"603":[116],"patients,":[117],"21":[118],"758":[119],"vs":[126],"groups,":[128],"median":[130],"follow-up":[131],"times":[132],"1.51":[134],"years":[135,141],"(16":[136,142],"304":[137],"patient-years)":[138],"1.53":[140],"306":[143],"patient-years),":[144],"respectively.":[145],"Treatment":[146],"GLDs":[149],"was":[150,198,226,254,271,287],"associated":[151,199,227,255,272,289],"44%":[154],"(hazard":[155],"ratio":[156],"[HR]":[157],"0.56":[158],"[95%":[159,167,173],"confidence":[160],"interval":[161],"{CI}":[162],"0.49-0.64]),":[163],"15%":[164],"(HR":[165,244],"0.85":[166],"CI":[168,174,212,219,238,247],"0.73-0.99])":[169],"74%":[171],"(0.26":[172],"0.12-0.57])":[175],"lower":[176,201,229,257,275,291],"CVD":[181,207,243,262],"hypoglycaemia,":[183],"respectively,":[184],"treatment.":[188,269],"In":[189],"separate":[190],"analyses":[191],"for":[192],"two":[194],"risks":[202],"mortality":[205,233,280],"(56%":[208],"[HR":[209,216,235],"0.44,":[210],"95%":[211,218,237,246],"0.28-0.70]":[213],"49%":[215],"0.51,":[217],"0.30-0.86],":[220],"respectively),":[221],"while":[222],"DPP-4":[223,284],"inhibitor":[224,285],"treatment":[225,253,286],"(41%":[234],"0.59,":[236],"0.51-0.67]),":[239],"but":[240],"not":[241],"0.87,":[245],"0.75-1.01).":[248],"CONCLUSIONS:":[249],"Novel":[250],"hypoglycaemia":[265],"Dapagliflozin":[270],"both":[278],"CVD,":[282],"whereas":[283],"only":[288],"mortality.":[295]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2585095576","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":14},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":18},{"year":2017,"cited_by_count":17}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2017-02-10T00:00:00"}
